lenvatinib,pembrolizumab
eisai pharmaceutical,merck
['rcc,(-irccs),(-srcc),(-urcc)', 'kcsm,(-skcsm)', 'lenva', 'pembro']
lenvatinib plus pembrolizumab improves pfs2 outcomes in advanced rcc #asco22 #kcsm #oncology 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.